An investigation to optimize angiogenesis within potential dermal replacements

Plastic and Reconstructive Surgery

Volumn 117, Issue 6, 2006, Pages 1876-1885

  Potter, Matthew J ^a   Linge, Claire ^a   Cussons, Paul ^a   Dye, Julian F ^a   Sanders, Roy ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; COLLAGEN; FIBRIN; FIBRONECTIN; GLYCOSAMINOGLYCAN; VITRONECTIN; CHONDROITIN SULFATE; DERMATAN SULFATE; MICROSPHERE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL CULTURE; CELL INVASION; COCULTURE; COMPUTER PROGRAM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PLACENTA; PRIORITY JOURNAL; SKIN TRANSPLANTATION; STATISTICAL ANALYSIS; ARTIFICIAL SKIN; CELL MOTION; COMPARATIVE STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EVALUATION; FEMALE; GEL; INSTRUMENTATION; METHODOLOGY; PHYSIOLOGY; PREGNANCY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CHONDROITIN SULFATES; COLLAGEN; CULTURE MEDIA; DERMATAN SULFATE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FEMALE; FIBRIN; FIBRONECTINS; GELS; GLYCOSAMINOGLYCANS; HUMANS; MICROSPHERES; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PREGNANCY; SKIN, ARTIFICIAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRONECTIN;

EID: 33646846246     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000218843.86011.f8     Document Type: Article

References (45)

1. Wysocki, A. B. Wound fluids and the pathogenesis of chronic wounds. J. Wound Ostomy Continence Nurs. 23: 283, 1996.
2. Sheridan, R. L., et al. Artificial skin in massive burns: Results to ten years. Eur. J. Plast. Surg. 17: 91, 1994 .
3. Heimbach, D., Luterman, A., Burke, J., et al. Artificial dermis for major burns: A multi-center randomized clinical trial. Ann. Surg. 208: 313, 1988.
4. Machens, H. G., Berger, A. C., and Mailaender, P. Bioartificial skin. Cells Tissues Organs 167: 88, 2000.
5. Molnar, J. A., DeFranzo, A. J., Hadaegh, H., Morykwas, M. J., Shen, P., and Argenta, L. C. Acceleration of Integra incorporation in complex tissue defects with subatmospheric pressure. Plast. Reconstr. Surg. 113: 1339, 2004.
6. Converse, J. M., Smahel, J., Ballantyne, D. R., Jr., and Harper, A. D. Inosculation of vessels of skin graft and host bed: A fortuitous encounter. Br. J. Plast. Surg. 28: 274, 1975.
7. Grzowski, S., et al. VEGF (165) gene modification improves angiogenesis of bioartificial skin grafts in nude mice. Presented at the European Conference of Scientists and Plastic Surgeons, Geneva, 2003.
8. Ruegg, C., Dormond, O., and Mariotti, A. Endothelial cell integrins and COX-2: Mediators and therapeutic targets of tumor angiogenesis. Biochim. Biophys. Acta 1654: 51, 2004.
9. Nakatsu, M. N., Sainson, R. C., Aoto, J. N., et al. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: The role of fibroblasts and angiopoietin-1. Microvasc. Res. 66: 102, 2003.
10. Losordo, D. W., and Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: Part I. Angiogenic cytokines. Circulation 109: 2487, 2004.
11. Distler, J. H., Hirth, A., Kurowska-Stolarska, M., Gay, R. E., Gay, S., and Distler, O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q. J. Nucl. Med. 47: 149, 2003.
12. Gabison, E. E., Hoang-Xuan, T., Mauviel, A., and Menashi, S. [Metalloproteinases and angiogenesis]. Pathol. Biol. (Paris) 51: 161, 2003.
13. Stupack, D. G., and Cheresh, D. A. Apoptotic cues from the extracellular matrix: Regulators of angiogenesis. Oncogene 22: 9022, 2003.
14. Mistry, A., Harbottle, R., Hart, S., and Hodivala-Dilke, K. M. Integrins and angiogenesis: Unlocking the route to gene therapy. Curr. Opin. Mol. Ther. 5: 603, 2003.
15. Nehls, V., and Drenckhahn, D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res. 50: 311, 1995.
16. Bootle-Wilbraham, C. A., Tazzyman, S., Thompson, W. D., Stirk, C. M., and Lewis, C. E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4: 269, 2001.
17. Dye, J. F., et al. Distinct patterns of human microvascular endothelial cell behaviour are determined by extracellular matrix composition. Endothelium Submitted for publication.
18. Ojeh, N. O., Frame, J. D., and Navsaria, H. A. In vitro characterization of an artificial dermal scaffold. Tissue Eng. 7: 457, 2001.
19. Vaissiere, G., Chevallay, B., Herbage, D., and Damour, O. Comparative analysis of different collagen-based biomaterials as scaffolds for long-term culture of human fibroblasts. Med. Biol. Eng. Comput. 38: 205, 2000.
20. Buckley, A., Hill, K. E., and Davidson, J. M. Collagen metabolism. Methods Enzymol. 163: 674, 1988.
21. Vranckx, J. J., et al. Cell suspensions of allogenic cultured keratinocytes serve as efficient carriers for ex vivo gene therapy and accelerated healing of full thickness wounds in a pig model. Presented at the European Conference of Scientists and Plastic Surgeons, Geneva, 2003.
22. Gruss, C. J., Satyamoorthy, K., Berking, C., et al. Stroma formation and angiogenesis by overexpression of growth factors, cytokines, and proteolytic enzymes in human skin grafted to SCID mice. J. Invest. Dermatol. 120: 683, 2003.
23. Sieminski, A. L., and Gooch, K. J. Salmon fibrin supports an increased number of sprouts and decreased degradation while maintaining sprout length relative to human fibrin in an in vitro angiogenesis model. J. Biomater. Sci. Polym. Ed. 15: 237, 2004.
24. Collen, A., Hanemaaijer, R., Lupu, F., et al. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrincollagen matrix. Blood 101: 1810, 2003.
25. Lafleur, M. A., Handsley, M. M., Knauper, V., Murphy, G., and Edwards, D. R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci. 115: 3427, 2002.
26. Vailhe, B., Lecomte, M., Wiernsperger, N., and Tranqui, L. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis 2: 331, 1998.
27. Chekanov, V. S., Rayel, R., Nikolaychik, V., et al. Direct fibrin injection to promote new collateral growth in hind limb ischemia in a rabbit model. J. Card. Surg. 17: 502; discussion 512, 2002.
28. Kipshidze, N., Kipiani, K., Beridze, N., et al. Therapeutic angiogenesis for patients with limb ischemia by utilization of fibrin meshwork: Pilot randomized controlled study. Int. Angiol. 22: 349, 2003.
29. Hojo, M., Inokuchi, S., Kidokoro, M., et al. Induction of vascular endothelial growth factor by fibrin as a dermal substrate for cultured skin substitute. Plast. Reconstr. Surg. 111: 1638, 2003.
30. Kroon, M. E., van Schie, M. L., van der Vecht, V., van Hinsbergh, V. W., and Koolwijk, P. Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix. Angiogenesis 5: 257, 2002.
31. Llames, S. G., Del Rio, M., Larcher, F., et al. Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin. Transplantation 77: 350, 2004.
32. Vogel, V., and Baneyx, G. The tissue engineering puzzle: A molecular perspective. Annu. Rev. Biomed. Eng. 5: 441, 2003.
33. Yi, M., Sakai, T., Fassler, R., and Ruoslahti, E. Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity. Proc. Natl. Acad. Sci. U.S.A. 100: 11435, 2003.
34. Birchler, M. T., Milisavlijevic, D., Pfaltz, M., et al. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. Laryngoscope 113: 1231, 2003.
35. Sottile, J., and Hocking, D. C. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol. Biol. Cell 13: 3546, 2002.
36. Yannas, I. V., Burke, J. F., Gordon, P. L., Huang, C., and Rubenstein, R. H. Design of an artificial skin: II. Control of chemical composition. J. Biomed. Mater. Res. 14: 107, 1980.
37. Lam, P. K., Chan, E. S., To, E. W., Lau, C. H., Yen, S. C., and King, W. W. Development and evaluation of a new composite Laserskin graft. J. Trauma 47: 918, 1999.
38. Fernandez-Botran, R., Gorantla, V., Sun, X., et al. Targeting of glycosaminoglycan-cytokine interactions as a novel therapeutic approach in allotransplantation. Transplantation 74: 623, 2002.
39. Tapon-Bretaudiere, J., Chabut, D., Zierer, M., et al. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis. Mol. Cancer Res. 1: 96, 2002.
40. Franzmann, E. J., Schroeder, G. L., Goodwin, W. J., Weed, D. T., Fisher, P., and Lokeshwar, V. B. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int. J. Cancer 106: 438, 2003.
41. Liu, N., Xu, X. M., Chen, J., et al. Hyaluronan-binding peptide can inhibit tumor growth by interacting with Bcl-2. Int. J. Cancer 109: 49, 2004.
42. Leach, J. B., et al. Development of photocrosslinkable hyaluronic acid-polyethylene glycol-peptide composite hydrogels for soft tissue engineering. J. Biomed. Mater. Res. 70A: 74, 2004.
43. Lees, V. C, Fan, T. P., and West D. C. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab. Invest. 73: 259, 1995.
44. Santhosh, A., Mathew, S., and Sudhakaran, P. R. Synthesis of sulphated proteoglycans by primary cultures of rat hepatocytes-modulation by matrix substratum. Mol. Cell. Biochem. 165: 1, 1996.
45. Vlodavsky, I., et al. Mammalian heparanase as mediator of tumor metastasis and angiogenesis. Isr. Med. Assoc. J. 2 (Suppl.): 37, 2000.